Literature DB >> 1463106

Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck.

R K Finley1, G T Verazin, D L Driscoll, L E Blumenson, H Takita, V Bakamjian, K Sako, W Hicks, N J Petrelli, D P Shedd.   

Abstract

In this retrospective review of 58 patients (12 females and 46 males) with pulmonary metastases of squamous cell carcinoma of the head and neck treated between January 1, 1970, and December 31, 1989, we evaluated their clinical courses and analyzed the outcomes of those who underwent pulmonary resection. For the entire group of patients, factors predictive of survival in those patients with a diagnosis of pulmonary metastases included pulmonary resection of metastases (p = 0.0001), locoregional control of the head and neck primary tumor at the time of diagnosis of pulmonary metastases (p = 0.007), TNM stage of the head and neck primary tumor (p = 0.02), a single nodule seen on the chest radiograph (p = 0.02), and disease-free interval (DFI) from the primary tumor of the head and neck of 2 years or more (p = 0.05). Twenty-four of 58 patients underwent thoracotomy for resection of metastases. Four (17%) were found to have a second primary tumor of the lung. Of the 20 remaining patients who underwent explorative surgery for possible pulmonary resection, 18 (90%) underwent complete resection of all malignant disease with an estimated 5-year survival of 29%. In these patients, a DFI of less than 1 year was associated with a 5-year survival rate of 0%, whereas a DFI of 1 to 2 years was associated with a 5-year survival rate of 43% and a DFI of 2 years or longer had a 5-year survival rate of 33%. The number of malignant pulmonary nodules that were resected ranged from one to five and was not significant in predicting survival (p = 0.19). Of eight patients who underwent the resection of more than one malignant pulmonary nodule, 50% survived 2 years, but none survived 5 years. Resection of a solitary pulmonary metastasis from squamous cell carcinoma of the head and neck resulted in long-term survival in selected patients. Important prognostic factors included locoregional control of the head and neck primary tumor, the number of nodules seen on chest radiograph, the TNM stage of the primary tumor, and the DFI from the head and neck primary tumor. The value of resection in patients with more than one malignant pulmonary nodule remains to be defined for this group of patients.

Entities:  

Mesh:

Year:  1992        PMID: 1463106     DOI: 10.1016/s0002-9610(05)80714-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  13 in total

1.  CT staging and surveillance of the thorax in patients with newly diagnosed and recurrent squamous cell carcinoma of the head and neck: is it necessary?

Authors:  Fergal Glynn; Sinead Brennan; Gerard O'Leary
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-08       Impact factor: 2.503

2.  Surgical Treatment for Pulmonary Metastasis of Head and Neck Cancer: Study of 58 Cases.

Authors:  Yuki Nakajima; Yoshihito Iijima; Hiroyasu Kinoshita; Hirohiko Akiyama; Takeshi Beppu; Hidetaka Uramoto; Tomomi Hirata
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-05-09       Impact factor: 1.520

3.  Surgical outcomes of pulmonary metastases from esophageal carcinoma diagnosed by both pathological and clinical criteria.

Authors:  Yoshiki Kozu; Shiaki Oh; Kazuya Takamochi; Kenji Suzuki
Journal:  Surg Today       Date:  2014-09-18       Impact factor: 2.549

4.  [Surgical therapy of lung metastases from head and neck cancer].

Authors:  S Macherey; S F Preuss; F Doerr; S Grönke; M Heldwein; A Quaas; T Zander; K Hekmat
Journal:  HNO       Date:  2014-12       Impact factor: 1.284

5.  Surgery for pulmonary malignancies in patients with a previous history of head and neck squamous cell carcinoma.

Authors:  Ryu Kanzaki; Masayoshi Inoue; Masato Minami; Yasushi Shintani; Tomoyuki Nakagiri; Soichiro Funaki; Mikihiko Kogo; Yoshiaki Yura; Hidenori Inohara; Noriyoshi Sawabata; Meinoshin Okumura
Journal:  Surg Today       Date:  2013-04-16       Impact factor: 2.549

6.  Pulmonary resection for metastatic head and neck cancer.

Authors:  Fengshi Chen; Makoto Sonobe; Kiyoshi Sato; Takuji Fujinaga; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

Review 7.  Current status of pulmonary metastasectomy from primary epithelial tumors.

Authors:  Tokujiro Yano; Fumihiro Shoji; Yoshihiko Maehara
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

8.  Long-term outcome and patterns of failure in patients with advanced head and neck cancer.

Authors:  Henrik Hauswald; Christian Simon; Simone Hecht; Juergen Debus; Katja Lindel
Journal:  Radiat Oncol       Date:  2011-06-10       Impact factor: 3.481

9.  Complete biochemical response after pulmonary metastasectomy in prostate adenocarcinoma.

Authors:  Jonathan Rush; Reet Pai; Rahul A Parikh
Journal:  Exp Hematol Oncol       Date:  2017-09-15

10.  Survival predictors after resection of lung metastases of head or neck cancers.

Authors:  Masaya Yotsukura; Tomonari Kinoshita; Mitsutomo Kohno; Keisuke Asakura; Ikuo Kamiyama; Katsura Emoto; Yuichiro Hayashi; Takashi Ohtsuka
Journal:  Thorac Cancer       Date:  2015-01-26       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.